03347 TIGERMED
- 34.750
- +0.450+1.31%
TIGERMED News
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to 118.38 Yuan From 116.32 Yuan
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to HK$102.23 From HK$80.36
UBS Adjusts Hangzhou Tigermed Consulting's Price Target to HK$126.22 From HK$138.82, Keeps at Buy
UBS Adjusts Hangzhou Tigermed Consulting's Price Target to 147.28 Yuan From 154.78 Yuan, Keeps at Buy
Nomura Adjusts Tigermed’s Price Target to HK$105.58 From HK$108.33, Keeps at Buy
Nomura Adjusts Tigermed’s Price Target to 122.78 Yuan From 119.66 Yuan, Nomura Keeps at Buy
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$108.33 From HK$115.13, Keeps at Buy
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to 122.78 Yuan From 125.87 Yuan, Keeps at Buy
Analysis
Price Target
No Data
